Drug Profile
Clindamycin/fosmidomycin
Alternative Names: Fosclin; Fosmidomycin/clindamycinLatest Information Update: 01 Nov 2014
Price :
$50
*
At a glance
- Originator Jomaa Pharma
- Class Antimalarials; Lincosamides; Organophosphorus compounds; Phosphonic acids; Small molecules
- Mechanism of Action Oxidoreductase inhibitors; Protein 50S ribosomal subunit inhibitors; Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Malaria
Most Recent Events
- 18 Sep 2014 Discontinued - Phase-II for Malaria (In children) in Mozambique (PO) (NCT01464138)
- 18 Sep 2014 Discontinued - Phase-II for Malaria in Africa (PO)
- 18 Sep 2014 Discontinued - Phase-II for Malaria in Asia (PO)